Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsTransplantation ChimeraBone Marrow TransplantationStem CellsGraft vs Leukemia EffectTissue DonorsMyeloablative AgonistsTreatment OutcomeBusulfanRemission InductionVidarabineGraft vs Tumor EffectRecurrenceGraft SurvivalLymphocyte TransfusionHistocompatibility TestingImmunosuppressive AgentsBone and BonesLeukemia, Myeloid, AcuteMultiple MyelomaLeukemiaRetrospective StudiesSiblingsCord Blood Stem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoietic Stem CellsCombined Modality TherapyMinor Histocompatibility AntigensCytomegalovirus InfectionsWhole-Body IrradiationLymphocyte DepletionSalvage TherapyDisease-Free SurvivalAntilymphocyte SerumSurvival AnalysisHistocompatibilityMyelodysplastic SyndromesLiver TransplantationSurvival RateVirus ActivationNeoplasm, ResidualPrecursor Cell Lymphoblastic Leukemia-LymphomaMelphalanChimerismHepatic Veno-Occlusive DiseaseTime FactorsMesenchymal Stem Cell TransplantationCyclophosphamideT-LymphocytesAcute DiseaseHematopoietic Stem Cell MobilizationAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirusAnemia, AplasticPrimary MyelofibrosisHLA AntigensCell TransplantationBone MarrowBone Marrow CellsFollow-Up StudiesHematologic DiseasesKidney TransplantationEmbryonic Stem CellsAntigens, CD34PrognosisLeukemia, Myeloid, Accelerated PhaseTransplantation ImmunologyImmunosuppressionAntibodies, NeoplasmCytarabineRoseolovirus InfectionsLeukemia, MyeloidBenzamidesAdult Stem CellsLymphoproliferative DisordersImmunocompromised HostAntineoplastic AgentsFusion Proteins, bcr-ablNuclear FamilyReceptors, Purinergic P2X5Hodgkin DiseasePyrimidinesGraft RejectionGranulocyte Colony-Stimulating FactorInfectionGanciclovirBone RemodelingLymphoma, Non-HodgkinCell DifferentiationFatal OutcomeLeukocyte TransfusionImmunotherapy, AdoptivePiperazines